×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ADMA – adma biologics inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ADMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/24
06:46 am
adma
ADMA Legal Notification: ADMA Biologics Securities Class Action Investigation Ongoing – Investors with Losses after 29% Stock Drop Notified to Contact BFA Law
Low
Report
ADMA Legal Notification: ADMA Biologics Securities Class Action Investigation Ongoing – Investors with Losses after 29% Stock Drop Notified to Contact BFA Law
4/23
11:17 am
adma
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
4/22
09:00 pm
adma
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
Low
Report
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
4/22
06:05 am
adma
$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation
Low
Report
$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation
4/21
04:53 pm
adma
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
4/21
04:11 pm
adma
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
4/21
09:30 am
adma
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating
Medium
Report
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating
4/20
07:01 pm
adma
ADMA Biologics (ADMA) was given a new $21.00 price target by Canaccord Genuity Group Inc..
Low
Report
ADMA Biologics (ADMA) was given a new $21.00 price target by Canaccord Genuity Group Inc..
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/15
04:40 pm
adma
Form ARS ADMA BIOLOGICS, INC. For: Dec 31
Low
Report
Form ARS ADMA BIOLOGICS, INC. For: Dec 31
4/15
04:35 pm
adma
Form DEFA14A ADMA BIOLOGICS, INC.
Low
Report
Form DEFA14A ADMA BIOLOGICS, INC.
4/15
04:31 pm
adma
Form DEF 14A ADMA BIOLOGICS, INC. For: Jun 02
Low
Report
Form DEF 14A ADMA BIOLOGICS, INC. For: Jun 02
4/3
09:01 pm
adma
Form 4 ADMA BIOLOGICS, INC. For: Apr 01 Filed by: Kestenberg-Messina Kaitlin M.
Low
Report
Form 4 ADMA BIOLOGICS, INC. For: Apr 01 Filed by: Kestenberg-Messina Kaitlin M.
3/27
07:06 am
adma
Form 8-K ADMA BIOLOGICS, INC. For: Mar 27
High
Report
Form 8-K ADMA BIOLOGICS, INC. For: Mar 27
3/26
03:12 pm
adma
Form SCHEDULE 13G/A ADMA BIOLOGICS, INC. Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A ADMA BIOLOGICS, INC. Filed by: VANGUARD GROUP INC
3/17
09:01 pm
adma
Form 4 ADMA BIOLOGICS, INC. For: Mar 13 Filed by: Guiheen Lawrence P.
Medium
Report
Form 4 ADMA BIOLOGICS, INC. For: Mar 13 Filed by: Guiheen Lawrence P.
3/17
09:00 pm
adma
Form 4 ADMA BIOLOGICS, INC. For: Mar 16 Filed by: Grossman Adam S
Medium
Report
Form 4 ADMA BIOLOGICS, INC. For: Mar 16 Filed by: Grossman Adam S
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/20
Form 8-K ADMA BIOLOGICS, INC. For: Mar 20
36.6%
1/9 ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook 17.6%
3/3 Form 4 ADMA BIOLOGICS, INC. For: Feb 28 Filed by: Grossman Adam S 10.8%
3/10 Form SEC STAFF LETTER ADMA BIOLOGICS, INC. 8.6%
5/21 ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 8.5%
8/23 Form 8-K ADMA BIOLOGICS, INC. For: Aug 23 7.7%
9/5 Form 8-K ADMA BIOLOGICS, INC. For: Aug 29 7.3%
5/8 Q1/2019 3/31/2019 EPS -0.280 ZacksConsensus -0.320 ActVsEst 0.040 - Beat 7.3%
7/8 Form 8-K ADMA BIOLOGICS, INC. For: Jul 02 6.9%
10/21 ADMA Biologics Announces First Commercial Sales of ASCENIV™ 6.5%
1/9 ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook 17.6%
3/3 Form 4 ADMA BIOLOGICS, INC. For: Feb 28 Filed by: Grossman Adam S 10.8%
3/10 Form SEC STAFF LETTER ADMA BIOLOGICS, INC. 8.6%
5/21 ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 8.5%
8/23 Form 8-K ADMA BIOLOGICS, INC. For: Aug 23 7.7%
9/5 Form 8-K ADMA BIOLOGICS, INC. For: Aug 29 7.3%
5/8 Q1/2019 3/31/2019 EPS -0.280 ZacksConsensus -0.320 ActVsEst 0.040 - Beat 7.3%
7/8 Form 8-K ADMA BIOLOGICS, INC. For: Jul 02 6.9%
10/21 ADMA Biologics Announces First Commercial Sales of ASCENIV™ 6.5%
TOP News Decliners
2/6
ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock
-14.3%
6/6 Form 8-K ADMA BIOLOGICS, INC. For: Jun 06 -12.3%
10/2 Form 8-K ADMA BIOLOGICS, INC. For: Oct 02 -11.2%
11/6 Form 8-K ADMA BIOLOGICS, INC. For: Nov 06 -10.5%
3/5 ADMA Biologics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 -10.4%
3/3 New U.S. patent lifts Adma Biologics, up 17% premarket [Seeking Alpha] -9.9%
3/16 ADMA Biologics Inc (NASDAQ: ADMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $14.00. -9.1%
10/3 Form 8-K ADMA BIOLOGICS, INC. For: Oct 03 -8.5%
3/9 Form SC 13G/A ADMA BIOLOGICS, INC. Filed by: BlackRock Inc. -7.5%
12/3 ADMA Biologics Inc (NASDAQ: ADMA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -7.0%
6/6 Form 8-K ADMA BIOLOGICS, INC. For: Jun 06 -12.3%
10/2 Form 8-K ADMA BIOLOGICS, INC. For: Oct 02 -11.2%
11/6 Form 8-K ADMA BIOLOGICS, INC. For: Nov 06 -10.5%
3/5 ADMA Biologics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 -10.4%
3/3 New U.S. patent lifts Adma Biologics, up 17% premarket [Seeking Alpha] -9.9%
3/16 ADMA Biologics Inc (NASDAQ: ADMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $14.00. -9.1%
10/3 Form 8-K ADMA BIOLOGICS, INC. For: Oct 03 -8.5%
3/9 Form SC 13G/A ADMA BIOLOGICS, INC. Filed by: BlackRock Inc. -7.5%
12/3 ADMA Biologics Inc (NASDAQ: ADMA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -7.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: